Research & development
-
Gilead, AstraZeneca and Pfizer likely to win the COVID-19 treatment development race
Gilead, AstraZeneca and Pfizer are leading the race to develop effective COVID-19 treatments, with Gilead’s remdesivir standing out for its proven results. Discover how these pharma giants are shaping the future of pandemic response.
-
Givaudan acquires French biotechnology company
Givaudan has acquired innovative French biotech company Alderys, strengthening its expertise in bio-engineering and sustainable solutions for the chemical, cosmetic, and nutrition industries. This move expands Givaudan’s portfolio of natural, bio-sourced products—discover how this acquisition supports their long-term growth and commitment to sustainability.
-
New cannabis rules announced
Major changes to cannabis regulations mean new rules for cannabidiol and THC. Werksmans Attorneys unpacks exactly what’s allowed, what’s not, and what these updates to the Medicines Act could mean for your business or wellness products—find out how the law affects you.
-
Asymptomatic testing will be vital in next phase of COVID-19 pandemic
With virus resurgence a growing concern, expanding COVID-19 testing to include asymptomatic individuals is now crucial. Discover why experts believe this shift will play a vital role in controlling future outbreaks and how new FDA approvals are driving rapid change in global testing strategies.
-
CBD down-scheduled to an SO product in SA
CBD is now down-scheduled in South Africa, making it more accessible for general health use. Discover how recent changes by SAHPRA could open new opportunities for the local CBD industry—read more about what this means for your business.
-
Pharmaceutical companies contribute to the fight against COVID-19 in SA
IPASA and its member companies are working hand-in-hand with government and industry partners, donating funds, medicines, and vaccines to help fight COVID-19 in South Africa. Discover how these efforts are supporting healthcare workers and advancing real solutions—read more about their ongoing impact.
